Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-10 Purchase | 2023-08-16 6:01 pm | Indaptus Therapeutics Inc. | INDP | Anderson Glen R. 10% Owner | 103,352 | $2.0937 | $216,388 | 1,190,400 (Indirect) | View |
| 2022-01-31 Purchase | 2022-12-19 9:06 pm | Indaptus Therapeutics Inc. | INDP | Litchev Boyan Vesselinov Chief Medical Officer | 1,150 | $2.1914 | $2,520 | 1,150 (Direct) | View |
| 2022-11-18 Purchase | 2022-11-22 08:00 am | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 10,000 | $1.8945 | $18,945 | 75,374 (Direct) | View |
| 2022-09-08 Purchase | 2022-09-12 09:00 am | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 10,308 | $2.8 | $28,862 | 65,374 (Direct) | View |
| 2022-09-07 Purchase | 2022-09-09 09:00 am | Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Business Officer | 150 | $2.62 | $393 | 150 (Direct) | View |
| 2022-09-06 Purchase | 2022-09-08 09:00 am | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 9,692 | $2.5558 | $24,771 | 55,066 (Direct) | View |
| 2022-06-06 Purchase | 2022-06-07 08:00 am | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 19,727 | $2.63 | $51,882 | 45,374 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 5:08 pm | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 20,000 | $5.0021 | $100,043 | 1,368,356 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-22 Option Award | 2024-01-23 4:15 pm | N/A 2034-01-22 | Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Operating Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-23 4:15 pm | N/A 2034-01-22 | Indaptus Therapeutics Inc. | INDP | Waltzman Roger J. Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-23 4:15 pm | N/A 2034-01-22 | Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-23 4:15 pm | N/A 2034-01-22 | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-23 4:15 pm | N/A 2034-01-22 | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 43,250 | $0 | 43,250 (Direct) | View |
| 2023-08-07 Option Award | 2023-08-07 5:25 pm | N/A 2033-08-07 | Indaptus Therapeutics Inc. | INDP | Waltzman Roger J. Chief Medical Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 4:15 pm | N/A 2033-05-25 | Indaptus Therapeutics Inc. | INDP | Karah Hila Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 4:15 pm | N/A 2033-05-25 | Indaptus Therapeutics Inc. | INDP | Hayes William B Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 4:15 pm | N/A 2033-05-25 | Indaptus Therapeutics Inc. | INDP | Gilbert Mark John Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 4:15 pm | N/A 2033-05-25 | Indaptus Therapeutics Inc. | INDP | Pomerantz Roger Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 4:15 pm | N/A 2033-05-25 | Indaptus Therapeutics Inc. | INDP | MADDALUNA ANTHONY J Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-14 5:58 pm | N/A 2033-02-13 | Indaptus Therapeutics Inc. | INDP | Martell Robert Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 4:05 pm | N/A 2033-01-18 | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 4:05 pm | N/A 2033-01-18 | Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Business Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 4:05 pm | N/A 2033-01-18 | Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 4:05 pm | N/A 2033-01-18 | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 43,250 | $0 | 43,250 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-03 4:31 pm | N/A 2032-09-30 | Indaptus Therapeutics Inc. | INDP | Karah Hila Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-03 4:30 pm | N/A 2032-09-30 | Indaptus Therapeutics Inc. | INDP | Pomerantz Roger Director | 81,000 | $0 | 81,000 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-03 4:30 pm | N/A 2032-09-30 | Indaptus Therapeutics Inc. | INDP | Gilbert Mark John Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-03 4:30 pm | N/A 2032-09-30 | Indaptus Therapeutics Inc. | INDP | O'CALLAGHAN BRIAN Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-03 4:30 pm | N/A 2032-09-30 | Indaptus Therapeutics Inc. | INDP | MADDALUNA ANTHONY J Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-03 4:30 pm | N/A 2032-09-30 | Indaptus Therapeutics Inc. | INDP | Hayes William B Director | 13,750 | $0 | 13,750 (Direct) | View |
Ownership | 2022-07-07 4:36 pm | N/A N/A | Indaptus Therapeutics Inc. | INDP | Anderson Glen R. 10% Owner | 0 | $0 | 1,087,048 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-28 4:30 pm | N/A 2032-02-25 | Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 7:08 pm | N/A 2032-02-01 | Indaptus Therapeutics Inc. | INDP | Litchev Boyan Vesselinov Chief Medical Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:31 pm | N/A 2032-01-26 | Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner | 43,350 | $0 | 43,350 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:30 pm | N/A 2032-01-26 | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:30 pm | N/A 2032-01-26 | Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Business Officer | 45,850 | $0 | 45,850 (Direct) | View |
| 2021-12-01 Option Award | 2021-12-08 9:58 pm | N/A 2031-12-01 | Indaptus Therapeutics Inc. | INDP | Gilbert Mark John Director | 20,000 | $0 | 20,000 (Direct) | View |